Issuance of Priority Review Voucher; Rare Pediatric Disease Product; Withdrawal

الملخص

The Food and Drug Administration (FDA) is withdrawing the notice that published in the Federal Register of September 30, 2021, that announced the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Register notice was published in error and is being withdrawn.